# Clinical Implications of FKBP5 in Stroke

Study · id `cardio:ct-nct05198037` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05198037](<https://clinicaltrials.gov/study/NCT05198037>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05198037

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

## Technical summary

Registry record NCT05198037. Randomized; double masking; primary purpose other. Start 2021-11-01 (actual); primary completion 2025-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose other
- Phase: Not applicable
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT05198037, source copy `cardio:ctgov-nct05198037-2022-01-20`, retrieved 2026-10-26)
- Started: 2021-11-01 (actual) (ClinicalTrials.gov record NCT05198037, source copy `cardio:ctgov-nct05198037-2022-01-20`, retrieved 2026-10-26)
- Primary completion: 2025-07 (anticipated) (ClinicalTrials.gov record NCT05198037, source copy `cardio:ctgov-nct05198037-2022-01-20`, retrieved 2026-10-26)
- Completion: 2025-07 (anticipated) (ClinicalTrials.gov record NCT05198037, source copy `cardio:ctgov-nct05198037-2022-01-20`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT05198037, source copy `cardio:ctgov-nct05198037-2022-01-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05198037-2022-01-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Implications of FKBP5 in Stroke
- Condition: Stroke
- Intervention (Device): Bihemispheric tDCS
- Lead sponsor: Taipei Veterans General Hospital, Taiwan
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Taipei Veterans General Hospital, Taiwan (`cardio:org-taipei-veterans-general-hospital-taiwan`)

## Provenance

Content hash: eacad94a9cfbc6731de42fc3a30890a6150844909fc3d34296b75af15b9dc19c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
